UPEXI commits to 1.25% annual market cap fee in stock for 3-year advisory deal

summarizeSummary

UPEXI signed a three-year advisory agreement with Hivemind Capital Partners, agreeing to pay an annual fee of 1.25% of its market capitalization in common stock, leading to continuous shareholder dilution.

check_boxKey Events · Financing and Capital Events · UPXI

• Advisory Services Agreement

  UPEXI engaged Hivemind Capital Partners, LLC for a three-year term to provide advisory and consulting services on business, operations, and capital markets strategies, effective June 22, 2026.

• Equity-Based Compensation

  The advisor will receive an annual fee equal to 1.25% of UPEXI's market capitalization, payable quarterly in common stock. The first measurement date for this fee is June 30, 2026.

• Ongoing Dilution

  This recurring issuance of shares for advisory fees will lead to continuous dilution for existing shareholders over the three-year term, impacting the company's equity structure.

• Significant Contingent Liability

  The agreement stipulates that if UPEXI materially breaches the contract, it could be obligated to pay the full remaining three years of advisory fees in cash, representing a substantial financial commitment.

auto_awesomeAnalysis · UPXI · Crypto Assets

UPEXI has entered a three-year advisory agreement with Hivemind Capital Partners, committing to an annual fee equivalent to 1.25% of its market capitalization, payable in common stock. This ongoing equity issuance will result in significant dilution for existing shareholders, especially given the company's recent substantial net losses. The agreement also includes a clause that could obligate UPEXI to pay the full remaining term's fees in cash if it breaches the contract, creating a notable contingent liability.